Jm. Guralnik et al., Progressive versus catastrophic loss of the ability to walk: Implications for the prevention of mobility loss, J AM GER SO, 49(11), 2001, pp. 1463-1470
Citations number
30
Categorie Soggetti
Public Health & Health Care Science","General & Internal Medicine
OBJECTIVES: Loss of mobility is an important functional outcome that can ha
ve devastating effects on quality of life and the ability of older persons
to remain independent in the community. Although a large amount of research
has been done on risk factors for disability onset, little work has focuse
d on the pace of disability progression. This study characterizes the devel
opment of severe walking disability over time and evaluates risk factors an
d subsequent mortality as they relate to mobility disability with progressi
ve or catastrophic onset.
DESIGN: Population-based prospective cohort study with annual follow-up ass
essments for up to 7 years
SETTING: Three communities of the Established Populations for Epidemiologic
Studies of the Elderly.
PARTICIPANTS: There were 5,355 persons not disabled at baseline and the fir
st follow-up who had adequate data available to classify mobility disabilit
y during subsequent follow-ups.
MEASUREMENTS: Severe mobility disability was defined as the need for help f
rom a person to walk across a room or inability to walk across a room. Thos
e developing severe mobility disability were classified as having progressi
ve mobility disability if they had been unable to walk half a mile in eithe
r of the prior 2 years. They were classified as having catastrophic mobilit
y disability if they reported having been able to walk half a mile in two p
revious annual interviews.
RESULTS: The overall incidence of severe mobility disability was 11.6 cases
/1,000 person years. Those age 85 and older or having three or ii-tore chro
nic conditions at baseline were significantly more likely to develop progre
ssive disability than catastrophic disability. Stroke, hip fracture, and ca
ncer occurring during follow-up were associated with very high risk of seve
re mobility disability. For stroke and hip fracture, the risk was twice as
high for catastrophic disability as for progressive disability, but this di
fference did not reach statistical significance. Risk for catastrophic disa
bility from cancer was significantly greater than for progressive disabilit
y. Half of catastrophic disability subjects had stroke, hip fracture, or ca
ncer in the year immediately preceding this disability. Incident heart atta
ck did not predict severe mobility disability. Among those who developed se
vere mobility disability, type of disability did not influence subsequent s
urvival for the first 3 years, but beyond 3 years those with catastrophic d
isability had a relative risk of death of 0.4 (95% confidence interval 0.2-
0.9) compared with those with progressive disability.
CONCLUSION: The observation that risk factors and mortality outcomes were b
oth different for progressive and catastrophic mobility disability supports
the value of ascertaining the pace of disability development as a useful c
haracterization of disability. Further progress in developing prevention an
d treatment strategies may be made by taking the pace of disability develop
ment into account.